SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : MOVING NOW! -- Ignore unavailable to you. Want to Upgrade?

To: Ron who wrote (7580)5/13/2002 12:01:09 PM
From: Ron  Read Replies (1) | Respond to of 8046
 
Out AMCC for popcorn money... barely worth the trouble. It might go up again, but a little too choppy for my
trading method...



To: Ron who wrote (7580)5/13/2002 12:49:17 PM
From: nokomis  Respond to of 8046
 
CVSN (from research results) "Most of the emphasis on staving off cell death is focused on human therapeutics," said Steve Mento, Ph.D., Idun's President and CEO. "But as several of the presentations at this meeting have shown, there are many additional product opportunities being developed using the same technology. These opportunities are real, the potential markets are large, and the time to product revenue is much shorter.

siliconinvestor.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News